WO1996038122A1 - Composition dentifrice sous forme de comprime - Google Patents
Composition dentifrice sous forme de comprime Download PDFInfo
- Publication number
- WO1996038122A1 WO1996038122A1 PCT/ES1996/000123 ES9600123W WO9638122A1 WO 1996038122 A1 WO1996038122 A1 WO 1996038122A1 ES 9600123 W ES9600123 W ES 9600123W WO 9638122 A1 WO9638122 A1 WO 9638122A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition according
- dentifrice composition
- tablet
- dentifrice
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 239000000606 toothpaste Substances 0.000 title abstract description 22
- 229940034610 toothpaste Drugs 0.000 title abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000000346 sugar Nutrition 0.000 claims abstract description 11
- 150000008163 sugars Chemical class 0.000 claims abstract description 10
- 230000002070 germicidal effect Effects 0.000 claims abstract description 9
- 239000004088 foaming agent Substances 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims abstract description 7
- 239000003082 abrasive agent Substances 0.000 claims abstract description 6
- 239000000314 lubricant Substances 0.000 claims abstract description 6
- 235000019568 aromas Nutrition 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 5
- 238000004140 cleaning Methods 0.000 claims abstract description 5
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 5
- 239000003765 sweetening agent Substances 0.000 claims abstract description 5
- 125000001153 fluoro group Chemical class F* 0.000 claims abstract description 4
- 239000000551 dentifrice Substances 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 11
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 7
- 238000005056 compaction Methods 0.000 claims description 7
- 238000003113 dilution method Methods 0.000 claims description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- 239000000600 sorbitol Substances 0.000 claims description 6
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 5
- 229910019142 PO4 Inorganic materials 0.000 claims description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 5
- 229940041616 menthol Drugs 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
- 239000010452 phosphate Substances 0.000 claims description 5
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical group C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 5
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 5
- 239000000454 talc Substances 0.000 claims description 5
- 229910052623 talc Inorganic materials 0.000 claims description 5
- 229960003500 triclosan Drugs 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical group [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 4
- -1 sodium lauryl sulphosarcosinate Chemical compound 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 229940075582 sorbic acid Drugs 0.000 claims description 3
- 235000010199 sorbic acid Nutrition 0.000 claims description 3
- 239000004334 sorbic acid Substances 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- DUKKNDLIWRYBCT-UHFFFAOYSA-N 3-bromo-2-chlorophenol Chemical compound OC1=CC=CC(Br)=C1Cl DUKKNDLIWRYBCT-UHFFFAOYSA-N 0.000 claims description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002280 amphoteric surfactant Substances 0.000 claims description 2
- 125000000129 anionic group Chemical group 0.000 claims description 2
- 239000003945 anionic surfactant Substances 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 239000003093 cationic surfactant Substances 0.000 claims description 2
- 229960003260 chlorhexidine Drugs 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- 229940081974 saccharin Drugs 0.000 claims description 2
- 235000019204 saccharin Nutrition 0.000 claims description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 2
- 239000011775 sodium fluoride Substances 0.000 claims description 2
- 235000013024 sodium fluoride Nutrition 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical group OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- CKVCFYYFFUHCDP-UHFFFAOYSA-M sodium;phosphoric acid;fluoride Chemical compound [F-].[Na+].OP(O)(O)=O CKVCFYYFFUHCDP-UHFFFAOYSA-M 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 239000008187 granular material Substances 0.000 abstract description 5
- 210000003296 saliva Anatomy 0.000 abstract description 4
- 239000000001 dental powder Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 230000004913 activation Effects 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 description 9
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 6
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 206010039424 Salivary hypersecretion Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 208000026451 salivation Diseases 0.000 description 5
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 4
- 229940038472 dicalcium phosphate Drugs 0.000 description 4
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 4
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 3
- 239000005770 Eugenol Substances 0.000 description 3
- 235000006679 Mentha X verticillata Nutrition 0.000 description 3
- 235000002899 Mentha suaveolens Nutrition 0.000 description 3
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 3
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000007907 direct compression Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 229960002217 eugenol Drugs 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 3
- 229940075559 piperine Drugs 0.000 description 3
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 3
- 235000019100 piperine Nutrition 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000220223 Fragaria Species 0.000 description 2
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- BLXGLHZAGQSPEQ-UHFFFAOYSA-K [F].[Na+].[Na+].[Na+].[O-]P([O-])([O-])=O Chemical compound [F].[Na+].[Na+].[Na+].[O-]P([O-])([O-])=O BLXGLHZAGQSPEQ-UHFFFAOYSA-K 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 238000007908 dry granulation Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- BFDWBSRJQZPEEB-UHFFFAOYSA-L sodium fluorophosphate Chemical compound [Na+].[Na+].[O-]P([O-])(F)=O BFDWBSRJQZPEEB-UHFFFAOYSA-L 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- OECHMUONYSVUHV-UHFFFAOYSA-I tricalcium;carbonate;phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C([O-])=O.[O-]P([O-])([O-])=O OECHMUONYSVUHV-UHFFFAOYSA-I 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0216—Solid or semisolid forms
- A61K8/022—Powders; Compacted Powders
- A61K8/0225—Granulated powders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
Definitions
- the present invention relates to a dentifrice composition presented in the form of a tablet specially designed for use in oral hygiene without using a toothbrush.
- This patent refers to a toothpaste presented in powder or tablet form which has been obtained by direct compression.
- the tablets obtained by direct compression that is without prior granulation provide little homogeneity in the weight of the batches obtained.
- they have little consistency so that when they break in the mouth they disintegrate into particles with a size similar to that of the powder, which inhibits the salivation action of the mouth. Consequently, a brush and water should be used to achieve proper cleaning of the teeth.
- said direct compression of the powder Toothpaste entails inconveniences in terms of obtaining pills in perfect condition, that is, without exfoliation or "caping" during compression, and obtaining pills with a final non-homogeneous weight in each of the lots obtained by said procedure .
- the tablet-shaped composition of the present invention does not require rinsing. final, although this is preferable.
- the dentifrice composition in tablet form, object of the present invention comprises: an abrasive agent between 15 and 70%, a foaming agent between 0.2 and 4.1%, solid sugars between 41 and 80%, and lubricants between 0 , 6 and 6%.
- an abrasive agent is understood as a phosphate or an alkaline earth carbonate, the alkaline earth phosphate being anhydrous dicalcium phosphate, dihydrated phosphate, sodium polyphosphates or mixtures of the foregoing and 30% by weight being present in a preferred embodiment of the invention.
- the large amount of sugars used allows activating the salivation of the mouth thereby favoring the dissolution of the tablet or of the portions or granules obtained when said tablet is broken in the mouth.
- the water cleaning effect is obtained by activating saliva and the effect Mechanical brush is achieved by measuring the portions or granules obtained when the tablet is broken.
- the present dentifrice composition presented in the form of a tablet, thus allows oral hygiene to be performed without the toothbrush and toothpaste or toothpaste currently used, as well as water.
- obtaining a toothpaste in the form of a tablet entails a series of technical and utilization advantages that will be described below.
- the use of a tablet to perform oral hygiene is much more comfortable and in turn requires fewer conditions inherent in its purpose.
- Presenting a toothpaste in tablet form provides easy handling.
- the tablet is a compact unit and not broken down as is the case with tooth dust.
- the same amount of toothpaste occupies less space in tablet than in powder.
- the composition of the invention does not contain water, nor does it easily absorb ambient humidity, whereby the germicidal action is optimal. In the case, unlikely, that moisture absorbed its content in adjuvants (parahydroxybenzoates, sorbic acid, etc.) guarantees its stability.
- germicidal agents in the presence of water can be presented in an ionic form, and it is known that any germicide in an ionic form decreases its effectiveness, even substantially inhibiting it over time.
- the dentifrice composition of the invention comprises germicidal agents such as triclosan, bromochlorophenol or chlorhexidine, components, which even at very low concentrations inhibit the proliferation of the microorganisms that form the plaque bacterial, in addition to providing long-acting antiseptic action.
- germicidal agents such as triclosan, bromochlorophenol or chlorhexidine
- the dentifrice composition according to the present invention further comprises fluorine salts to protect dental plaque between 0.05 and 0.2%, preferably 0.15%, such as sodium fluoride and sodium monofluor phosphate; aromas between 1 and 2%, preferably fruity and menthol aromas present in 1% to give a pleasant smell; sweeteners between 0.001 and 0.15%, preferably saccharin present in 0.1% to flavor the tablet and preservatives between 0.02 and 1.5%, preferably 0.3%, such as for example sorbic acid and parahydroxybenzoates.
- fluorine salts to protect dental plaque between 0.05 and 0.2%, preferably 0.15%, such as sodium fluoride and sodium monofluor phosphate
- aromas between 1 and 2%, preferably fruity and menthol aromas present in 1% to give a pleasant smell
- sweeteners between 0.001 and 0.15%, preferably saccharin present in 0.1% to flavor the tablet and preservatives between 0.02 and 1.5%, preferably 0.3%, such as for example sorb
- hypoglycemic sugars is substantially higher than the dentifrices known so far. This substantially higher amount has the function of activating the salivation of the mouth and thus facilitating the dissolution of the tablet in the same.
- saliva is an antiseptic that increases the effectiveness of any active substance soluble in it. Being antiseptic, saliva acts as a natural defense of the oral cavity.
- a dentifrice tablet which has the advantage that when the mouth is broken by the action of the teeth, the salivation action is not inhibited.
- the abrasive efficiency of the tablet is greater than that of the powder, without ever damaging the tooth enamel or gums, so it can be used with a good result without the need of the brush. This is due, on the one hand, to the increase of the grain size since the granulometry of the dental powder is between 2 and 20 ⁇ , while the size of the portions of the tablet are much larger and therefore provide a greater abrasive effect.
- the hardness that dicalcium phosphate provides for being anhydrous, that is, free of water. On the contrary, in the presence of water the hardness is inferior since the most stable structure is the hydrated one and this one contributes lower hardness values.
- the following steps are carried out: the components of the composition are mixed by the dilution method; a first compaction is performed; the tablet obtained is granulated dry; and finally a second compaction is carried out which allows obtaining the tablet of the invention.
- the components of the composition are mixed using the same method of dilutions; the powder moistened with a binder solution is wet granulated in a granulator or the like; It is dried in a static or fluid bed stove, and finally, it is compacted.
- the tablet obtained according to said procedure small portions, granules, with a size larger than those of the dental powder are obtained because, on the one hand, the tablet of the present invention does not contain disintegrants and, on the other, due to the double compression performed in the procedure for obtaining it.
- Such granules take longer to melt in the mouth, thereby achieving that the disinfectant and abrasive action is prolonged for longer.
- the prior wet or dry granulation technique allows batches of tablets with a homogeneous final weight and with the desired hardness to be obtained.
- a preferred embodiment of the invention consists in presenting the colored or colorless tablets.
- Edible tablet The sugars used in the tablet are sugars that have no negative effect on diabetics.
- This example was based on the procedure widely known as dry granulation prior granulation.
- Triclosan (IRGASAN D.P. 300) 0, 20 Aroma mint piperine menthol 1, 00 Aroma winter grenn oil Aroma eugenol Aroma strawberry
- C.S. means sufficient quantity for 100% Once all components were mixed by the dilution method, a first compaction was performed.
- This example was based on the procedure widely known as wet granulation prior granulation.
- Dicalcium phosphate dihydrate 20.00 Anhydrous dicalcium phosphate Calcium carbonate 20, 00 Monofluor sodium phosphate 0,, 78 15 Triclosan (IRGASAN DP 300) 0,, 20 Aroma mint piperine menthol Aroma winter grenn oil o,, 30 Aroma eugenol o,, 10 Strawberry flavor 20 Talc 1,. 00
- Triclosan (IRGASA D.P. 300) 0.20
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
La composition dentifrice comprend entre 15 et 70 % d'un agent abrasif, entre 0,2 et 4,1 % d'un agent moussant, entre 41 et 80 % de sucres solides, et entre 0,6 et 6 % de lubrifiants, et en outre elle comprend entre 0,05 et 0,2 %, de préférence 0,15 %, de sels de fluor, entre 1 et 2 %, de préférence 1 %, d'arômes, entre 0,01 et 0,15 %, de préférence 0,1 %, d'édulcorants, entre 0,02 et 1,5 %, de préférence, 3 % d'agents conservateurs. Elle permet de réaliser l'hygiène buccale en se passant de la brosse à dents et de la pâte dentifrice ou de la poudre dentaire, ainsi que de l'eau. L'effet nettoyant de l'eau est obtenu par l'activation de la salive et l'effet mécanique de la brosse à dents est obtenu par la taille des morceaux ou des granules obtenus lorsque le comprimé se casse. Il ne contient pas d'eau, et n'absorbe pas facilement l'humidité ambiante, et par conséquent son action germicide est optimale. Il est facile à utiliser.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9501093A ES2092967B1 (es) | 1995-06-01 | 1995-06-01 | Composicion dentifrica en forma de comprimido. |
ESP9501093 | 1995-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996038122A1 true WO1996038122A1 (fr) | 1996-12-05 |
Family
ID=8290597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES1996/000123 WO1996038122A1 (fr) | 1995-06-01 | 1996-05-30 | Composition dentifrice sous forme de comprime |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2092967B1 (fr) |
WO (1) | WO1996038122A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3106059A1 (fr) | 2020-01-14 | 2021-07-16 | Jean Dominque DANA | Composition dentifrice comestible à sucer ou à macher, procédé de préparation de ladite composition dentifrice |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3151028A (en) * | 1958-10-31 | 1964-09-29 | Lever Brothers Ltd | Dental tablet |
US4411885A (en) * | 1980-09-30 | 1983-10-25 | Barels Ronald R | Vitamin E oil based dentifrice |
GB2163348A (en) * | 1984-08-21 | 1986-02-26 | Dentab U K Limited | Tooth cleaning tablet |
WO1988010110A1 (fr) * | 1987-06-25 | 1988-12-29 | Dentab, Inc. | Tablette de fluoruration et de nettoyage des dents |
US4978521A (en) * | 1990-01-03 | 1990-12-18 | John Duncan Blue | Color coded flavored dentifrice toothpowders |
ES2023295A6 (es) * | 1989-08-25 | 1992-01-01 | Colgate Palmolive Co | Composicion oral antibacteriana, anti-placa y anti-calculos. |
-
1995
- 1995-06-01 ES ES9501093A patent/ES2092967B1/es not_active Expired - Fee Related
-
1996
- 1996-05-30 WO PCT/ES1996/000123 patent/WO1996038122A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3151028A (en) * | 1958-10-31 | 1964-09-29 | Lever Brothers Ltd | Dental tablet |
US4411885A (en) * | 1980-09-30 | 1983-10-25 | Barels Ronald R | Vitamin E oil based dentifrice |
GB2163348A (en) * | 1984-08-21 | 1986-02-26 | Dentab U K Limited | Tooth cleaning tablet |
WO1988010110A1 (fr) * | 1987-06-25 | 1988-12-29 | Dentab, Inc. | Tablette de fluoruration et de nettoyage des dents |
ES2023295A6 (es) * | 1989-08-25 | 1992-01-01 | Colgate Palmolive Co | Composicion oral antibacteriana, anti-placa y anti-calculos. |
US4978521A (en) * | 1990-01-03 | 1990-12-18 | John Duncan Blue | Color coded flavored dentifrice toothpowders |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3106059A1 (fr) | 2020-01-14 | 2021-07-16 | Jean Dominque DANA | Composition dentifrice comestible à sucer ou à macher, procédé de préparation de ladite composition dentifrice |
WO2021144211A1 (fr) | 2020-01-14 | 2021-07-22 | Jean Dominique Dana | Composition dentifrice comestible à sucer ou à macher, procédé de préparation de ladite composition dentifrice |
Also Published As
Publication number | Publication date |
---|---|
ES2092967A1 (es) | 1996-12-01 |
ES2092967B1 (es) | 1997-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6054119A (en) | Preparation used in dental care | |
US6436370B1 (en) | Dental anti-hypersensitivity composition and method | |
US10058497B2 (en) | Oral hygiene products and method of using the same | |
ES2385236B2 (es) | Composición y método para reducir la desmineralización de los dientes. | |
US8192724B2 (en) | Oral care tablet | |
EP0273962A1 (fr) | Compositions pour l'action prolongee d'agents antiplaque | |
US10517808B2 (en) | Oral care formulation and method for the removal of tartar and plaque from teeth | |
US6696043B2 (en) | Teeth whitening composition in the form of a chewing gum | |
EP1928429A2 (fr) | Compositions effervescentes de soins buccaux et leurs methodes d'utilisation | |
US11723847B2 (en) | Dual component oral composition for enhancing remineralization of teeth | |
WO1996038122A1 (fr) | Composition dentifrice sous forme de comprime | |
JPS603285B2 (ja) | 口腔用組成物 | |
ES2566615T3 (es) | Composiciones anticaries que contienen faseolamina | |
CN114129456A (zh) | 速溶漱口水粉 | |
JP2005289848A (ja) | 歯磨剤 | |
JP2018123107A (ja) | 口腔ケア用固形組成物 | |
KR20020086064A (ko) | 숯가루를 함유하는, 니코틴 제거용 치약 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): BR CA JP MX US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |